CSIMarket
 


Revolution Medicines Inc   (RVMD)
Other Ticker:  
 

Cumulative Revolution Medicines Inc 's Working Capital Ratio for Trailing Twelve Months Period

RVMD's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

RVMD Working Capital Ratio for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Growth 41.2 % 38.73 % 31.31 % 378.63 % 679.61 %
Y / Y Current Assets Growth 8.27 % -26.92 % -23.38 % 29.87 % 29.12 %
Working Capital Ratio for Trailing Twelve Months Period 8.96 9.56 11.18 12.74 15.81
Total Ranking # 443 # 576 # 523 # 462 # 351
Seq. Current Liabilities Growth 15.32 % 10.58 % -4.79 % 16.3 % 13.3 %
Seq. Current Assets Growth 39.76 % -9.6 % -9.4 % -5.41 % -5.67 %


Working Capital Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to increase in Current Liabilities in the III. Quarter to $73 millions, average cumulative Working Capital Ratio for Trailing Twelve Months Period decreased to 8.96 below Revolution Medicines Inc average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Pharmaceuticals industry 69 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Revolution Medicines Inc . While Working Capital Ratio for Trailing Twelve Months Period overall ranking has improved so far to 443, from total ranking in previous quarter at 576.

What is Working Capital Ratio?
More about RVMD
Working Capital Ratio RVMD in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 70
Sector # 273
S&P 500 # 443


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
12.91 11.09 8.96
(Sep 30 2021)   (Sep 30 2022)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Biotechnology & Pharmaceuticals Industry Working Capital Ratio for Trailing Twelve Months Period
Aura Biosciences Inc   24.14 
Vicarious Surgical Inc   24.12 
Vor Biopharma Inc   23.71 
Lixte Biotechnology Holdings Inc.  23.38 
Cardiff Oncology inc   22.39 
Relay Therapeutics Inc   21.16 
Replimune Group Inc   20.99 
Alpha Pro Tech Ltd   20.77 
Celldex Therapeutics inc   20.02 
Monte Rosa Therapeutics Inc   19.89 
Achilles Therapeutics Plc  19.47 
Crispr Therapeutics Ag  18.43 
Organovo Holdings Inc   18.38 
Fusion Pharmaceuticals Inc   18.35 
Rubius Therapeutics Inc   18.31 
Collplant Biotechnologies Ltd   18.31 
Kymera Therapeutics Inc   17.84 
Arca Biopharma Inc   17.79 
Tarsus Pharmaceuticals Inc   17.72 
Passage Bio inc   17.34 
Inmune Bio Inc   16.94 
Immunovant Inc   16.87 
Neoleukin Therapeutics Inc   16.67 
Candel Therapeutics Inc   16.58 
4d Molecular Therapeutics Inc   16.20 
Anavex Life Sciences Corp   16.09 
Century Therapeutics inc   15.18 
Omega Therapeutics Inc   14.88 
In8bio Inc   14.59 
Renovacor Inc   14.51 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BRN's Profile

Stock Price

BRN's Financials

Business Description

Fundamentals

Charts & Quotes

BRN's News

Suppliers

BRN's Competitors

Customers & Markets

Economic Indicators

BRN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071